Rapamycin vs Metformin: Which Longevity Drug Is Right for You?
These are the two most-discussed longevity medications, and they’re very different tools. Rapamycin has the strongest animal lifespan data but is more potent and carries more risk, so it’s used in low, intermittent doses. Metformin is cheap, extremely well-tolerated, and has a huge human safety record, but its longevity benefit is less certain and it may blunt exercise gains.
Neither is proven to extend human lifespan, and some people use both. The right pick depends on your risk tolerance and goals.
Two different bets on aging
Both drugs target metabolic pathways tied to aging, but from opposite directions. Rapamycin inhibits mTOR, a growth pathway, nudging cells toward maintenance and cleanup. Metformin activates AMPK, an energy sensor, with broadly similar downstream themes. Think of them as two different levers on the same machine.
Head-to-head
| Factor | Rapamycin | Metformin |
|---|---|---|
| Animal lifespan data | Strongest of any drug | Mixed, weaker |
| Human safety record | Less established for longevity | Decades, extensive |
| Potency / risk | Higher | Lower |
| Dosing | Low, intermittent (often weekly) | Daily |
| Exercise concern | Not a known issue | May blunt training gains |
| Cost | Higher | Very low |
The case for rapamycin
Rapamycin’s appeal is its track record in animals, where it reliably extends lifespan across species, even when started later in life. That’s a compelling foundation. The trade-off is that it’s a real immunosuppressant, which is why longevity use relies on low, intermittent dosing and close oversight. We go deep in our rapamycin longevity guide.
The case for metformin
Metformin’s appeal is safety and simplicity: it’s been used by millions for decades, it’s inexpensive, and it’s well understood. The catch is that its longevity benefit for healthy people is less certain, and some evidence suggests it may blunt the gains from exercise, a real consideration for the fitness-focused. Our metformin longevity guide covers the nuances.
How to choose
A few honest guidelines. If you prioritize the strongest mechanistic and animal evidence and accept more risk and monitoring, rapamycin is the more aggressive bet. If you prioritize a long safety record and low cost, and especially if you have metabolic markers trending the wrong way, metformin is the gentler starting point, though serious trainers should weigh the exercise question. Some people, under medical guidance, use both for complementary mechanisms.
Match the tool to your goals.
HermanRx connects you with licensed physicians who can help you weigh rapamycin, metformin, or both against your health profile, with the monitoring each requires.
The shared caveat
Whichever you consider, keep expectations honest: neither is proven to extend human lifespan. They’re promising, mechanistically sensible bets that belong under medical supervision, not guaranteed anti-aging cures. A prescriber can weigh your labs, medications, and goals. Providers like HermanRx offer both metformin and rapamycin within a supervised menu.
Rapamycin offers the strongest animal evidence at higher risk; metformin offers a stellar safety record with a less certain payoff and an exercise caveat. Neither is proven in humans. Choose based on your risk tolerance and metabolic picture, with a physician guiding the call.
Frequently asked questions
Which has better evidence, rapamycin or metformin?
Rapamycin has the strongest animal lifespan data of any drug; metformin has a far longer human safety record but a less certain longevity benefit. Neither is proven to extend human lifespan.
Can I take both together?
Some people do, under medical guidance, because they work through different mechanisms. Combinations should be cleared and monitored by a prescriber.
Does metformin really interfere with exercise?
Some studies suggest it may blunt training adaptations, though results vary. If serious fitness is central to your goals, this is worth weighing.
Which is safer?
Metformin has the longer, broader safety record. Rapamycin is more potent and carries more risk, which is why longevity use relies on low, intermittent dosing and monitoring.